| Year |
Citation |
Score |
| 2024 |
Lennemann NJ, Corliss L, Maury W. Modification of N-Linked Glycan Sites in Viral Glycoproteins. Methods in Molecular Biology (Clifton, N.J.). 2762: 27-41. PMID 38315358 DOI: 10.1007/978-1-0716-3666-4_3 |
0.675 |
|
| 2023 |
Aguilar-Briseño JA, Elliff JM, Patten JJ, Wilson LR, Davey RA, Bailey AL, Maury WJ. Effect of Interferon Gamma on Ebola Virus Infection of Primary Kupffer Cells and a Kupffer Cell Line. Viruses. 15. PMID 37896854 DOI: 10.3390/v15102077 |
0.304 |
|
| 2023 |
Banerjee S, Hemmat MA, Shubham S, Gosai A, Devarakonda S, Jiang N, Geekiyanage C, Dillard JA, Maury W, Shrotriya P, Lamm MH, Nilsen-Hamilton M. Structurally Different Yet Functionally Similar: Aptamers Specific for the Ebola Virus Soluble Glycoprotein and GP1,2 and Their Application in Electrochemical Sensing. International Journal of Molecular Sciences. 24. PMID 36902059 DOI: 10.3390/ijms24054627 |
0.538 |
|
| 2022 |
Gourronc FA, Rebagliati MR, Kramer-Riesberg B, Fleck AM, Patten JJ, Geohegan-Barek K, Messingham KN, Davey RA, Maury W, Klingelhutz AJ. Adipocytes are susceptible to Ebola Virus infection. Virology. 573: 12-22. PMID 35690007 DOI: 10.1016/j.virol.2022.05.007 |
0.365 |
|
| 2022 |
Ekanger CT, Zhou F, Bohan D, Lotsberg ML, Ramnefjell M, Hoareau L, Røsland GV, Lu N, Aanerud M, Gärtner F, Salminen PR, Bentsen M, Halvorsen T, Ræder H, Akslen LA, ... Maury W, et al. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus. Frontiers in Cellular and Infection Microbiology. 12: 841447. PMID 35360113 DOI: 10.3389/fcimb.2022.841447 |
0.368 |
|
| 2022 |
Van Ert HA, Bohan DW, Rogers K, Fili M, Rojas Chávez RA, Qing E, Han C, Dempewolf S, Hu G, Schwery N, Sevcik K, Ruggio N, Boyt D, Pentella MA, Gallagher T, ... ... Maury W, et al. Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein. Microbiology Spectrum. e0267621. PMID 35080430 DOI: 10.1128/spectrum.02676-21 |
0.309 |
|
| 2021 |
Bohan D, Van Ert H, Ruggio N, Rogers KJ, Badreddine M, Aguilar Briseño JA, Elliff JM, Rojas Chavez RA, Gao B, Stokowy T, Christakou E, Kursula P, Micklem D, Gausdal G, Haim H, ... Maury W, et al. Phosphatidylserine receptors enhance SARS-CoV-2 infection. Plos Pathogens. 17: e1009743. PMID 34797899 DOI: 10.1371/journal.ppat.1009743 |
0.368 |
|
| 2021 |
Bohan D, Maury W. Enveloped RNA virus utilization of phosphatidylserine receptors: Advantages of exploiting a conserved, widely available mechanism of entry. Plos Pathogens. 17: e1009899. PMID 34555126 DOI: 10.1371/journal.ppat.1009899 |
0.36 |
|
| 2021 |
Lennemann NJ, Dillard J, Ruggio N, Cooney AL, Schaack GA, Davey RA, Maury W. A naturally occurring polymorphism in the base of Sudan virus glycoprotein decreases glycoprotein stability in a species-dependent manner. Journal of Virology. JVI0107321. PMID 34232742 DOI: 10.1128/JVI.01073-21 |
0.733 |
|
| 2021 |
Bohan D, Ert HV, Ruggio N, Rogers KJ, Badreddine M, Aguilar Briseño JA, Rojas Chavez RA, Gao B, Stokowy T, Christakou E, Micklem D, Gausdal G, Haim H, Minna J, Lorens JB, ... Maury W, et al. Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19. Biorxiv : the Preprint Server For Biology. PMID 34159331 DOI: 10.1101/2021.06.15.448419 |
0.368 |
|
| 2020 |
Giraldo MI, Xia H, Aguilera-Aguirre L, Hage A, van Tol S, Shan C, Xie X, Sturdevant GL, Robertson SJ, McNally KL, Meade-White K, Azar SR, Rossi SL, Maury W, Woodson M, et al. Envelope protein ubiquitination drives entry and pathogenesis of Zika virus. Nature. PMID 32641828 DOI: 10.1038/S41586-020-2457-8 |
0.37 |
|
| 2020 |
Rogers KJ, Shtanko O, Stunz LL, Mallinger LN, Arkee T, Schmidt ME, Bohan D, Brunton B, White JM, Varga SM, Butler NS, Bishop GA, Maury W. Frontline Science: CD40 signaling restricts RNA virus replication in Mϕs, leading to rapid innate immune control of acute virus infection. Journal of Leukocyte Biology. PMID 32441445 DOI: 10.1002/Jlb.4Hi0420-285Rr |
0.351 |
|
| 2020 |
Rogers KJ, Jones-Burrage S, Maury W, Mukhopadhyay S. TF protein of Sindbis virus antagonizes host type I interferon responses in a palmitoylation-dependent manner. Virology. 542: 63-70. PMID 32056669 DOI: 10.1016/J.Virol.2020.01.001 |
0.316 |
|
| 2019 |
Brunton B, Rogers K, Phillips EK, Brouillette RB, Bouls R, Butler NS, Maury W. TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis. Plos Neglected Tropical Diseases. 13: e0006983. PMID 31242184 DOI: 10.1371/Journal.Pntd.0006983 |
0.451 |
|
| 2019 |
Das A, Maury W, Lemon SM. TIM1 (HAVCR1): an Essential "Receptor" or an "Accessory Attachment Factor" for Hepatitis A Virus? Journal of Virology. 93. PMID 31092684 DOI: 10.1128/Jvi.01793-18 |
0.314 |
|
| 2019 |
Dragovich MA, Fortoul N, Jagota A, Zhang W, Schutt K, Xu Y, Sanabria M, Moyer DM, Moller-Tank S, Maury W, Zhang XF. Biomechanical characterization of TIM protein-mediated Ebola virus-host cell adhesion. Scientific Reports. 9: 267. PMID 30670766 DOI: 10.1038/S41598-018-36449-2 |
0.422 |
|
| 2018 |
Shubham S, Hoinka J, Banerjee S, Swanson E, Dillard JA, Lennemann NJ, Przytycka TM, Maury W, Nilsen-Hamilton M. A 2'FY-RNA Motif Defines an Aptamer for Ebolavirus Secreted Protein. Scientific Reports. 8: 12373. PMID 30120364 DOI: 10.1038/S41598-018-30590-8 |
0.698 |
|
| 2018 |
Brouillette RB, Phillips EK, Patel R, Mahauad-Fernandez W, Moller-Tank S, Rogers KJ, Dillard JA, Cooney AL, Martinez-Sobrido L, Okeoma C, Maury W. TIM-1 Mediates Dystroglycan-Independent Entry of Lassa Virus. Journal of Virology. PMID 29875238 DOI: 10.1128/Jvi.00093-18 |
0.513 |
|
| 2017 |
Das A, Hirai-Yuki A, González-López O, Rhein B, Moller-Tank S, Brouillette R, Hensley L, Misumi I, Lovell W, Cullen JM, Whitmire JK, Maury W, Lemon SM. TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions. Mbio. 8. PMID 28874468 DOI: 10.1128/Mbio.00969-17 |
0.405 |
|
| 2017 |
Lennemann NJ, Herbert AS, Brouillette R, Rhein B, Bakken RA, Perschbacher KJ, Cooney AL, Miller-Hunt CL, Ten Eyck P, Biggins J, Olinger G, Dye JM, Maury W. Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice. Journal of Virology. PMID 28615211 DOI: 10.1128/Jvi.00479-17 |
0.705 |
|
| 2017 |
Sinn PL, Coffin JE, Ayithan N, Holt KH, Maury W. Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins. Methods in Molecular Biology (Clifton, N.J.). 1628: 65-78. PMID 28573611 DOI: 10.1007/978-1-4939-7116-9_5 |
0.366 |
|
| 2017 |
Brouillette RB, Maury W. Production of Filovirus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus for Study of Filovirus Entry Mechanisms. Methods in Molecular Biology (Clifton, N.J.). 1628: 53-63. PMID 28573610 DOI: 10.1007/978-1-4939-7116-9_4 |
0.421 |
|
| 2017 |
Brouillette RB, Phillips EK, Ayithan N, Maury W. Differences in glycoprotein complex (GPC) receptor binding site accessibility prompt poor cross-reactivity of neutralizing antibodies between closely related arenaviruses. Journal of Virology. PMID 28100617 DOI: 10.1128/Jvi.01454-16 |
0.491 |
|
| 2016 |
Rhein BA, Brouillette RB, Schaack GA, Chiorini JA, Maury W. Characterization of human and murine T-cell immunoglobulin mucin domain 4 (TIM-4) IgV domain residues critical for Ebola virus entry. Journal of Virology. PMID 27122575 DOI: 10.1128/Jvi.00100-16 |
0.453 |
|
| 2015 |
Rhein BA, Powers LS, Rogers K, Anantpadma M, Singh BK, Sakurai Y, Bair T, Miller-Hunt C, Sinn P, Davey RA, Monick MM, Maury W. Interferon-γ Inhibits Ebola Virus Infection. Plos Pathogens. 11: e1005263. PMID 26562011 DOI: 10.1371/Journal.Ppat.1005263 |
0.358 |
|
| 2015 |
Rhein BA, Maury WJ. Ebola virus entry into host cells: identifying therapeutic strategies. Current Clinical Microbiology Reports. 2: 115-124. PMID 26509109 DOI: 10.1007/s40588-015-0021-3 |
0.401 |
|
| 2015 |
Lennemann NJ, Walkner M, Berkebile AR, Patel N, Maury W. The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2. The Journal of Infectious Diseases. PMID 26038399 DOI: 10.1093/Infdis/Jiv201 |
0.721 |
|
| 2015 |
Moller-Tank S, Maury W. Ebola virus entry: a curious and complex series of events. Plos Pathogens. 11: e1004731. PMID 25928849 DOI: 10.1371/Journal.Ppat.1004731 |
0.415 |
|
| 2014 |
Moller-Tank S, Maury W. Phosphatidylserine receptors: enhancers of enveloped virus entry and infection. Virology. 468: 565-80. PMID 25277499 DOI: 10.1016/J.Virol.2014.09.009 |
0.454 |
|
| 2014 |
Moller-Tank S, Albritton LM, Rennert PD, Maury W. Characterizing functional domains for TIM-mediated enveloped virus entry. Journal of Virology. 88: 6702-13. PMID 24696470 DOI: 10.1128/Jvi.00300-14 |
0.451 |
|
| 2014 |
Lennemann NJ, Rhein BA, Ndungo E, Chandran K, Qiu X, Maury W. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. Mbio. 5: e00862-13. PMID 24473128 DOI: 10.1128/Mbio.00862-13 |
0.743 |
|
| 2013 |
Moller-Tank S, Kondratowicz AS, Davey RA, Rennert PD, Maury W. Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. Journal of Virology. 87: 8327-41. PMID 23698310 DOI: 10.1128/Jvi.01025-13 |
0.505 |
|
| 2013 |
Jones PH, Maric M, Madison MN, Maury W, Roller RJ, Okeoma CM. BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1). Virology. 438: 37-49. PMID 23411007 DOI: 10.1016/J.Virol.2013.01.010 |
0.395 |
|
| 2013 |
Oakland M, Maury W, McCray PB, Sinn PL. Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral Vectors. Molecular Therapy. Nucleic Acids. 2: e69. PMID 23360952 DOI: 10.1038/Mtna.2012.60 |
0.325 |
|
| 2013 |
Kondratowicz AS, Hunt CL, Davey RA, Cherry S, Maury WJ. AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus. Journal of Virology. 87: 746-55. PMID 23115293 DOI: 10.1128/Jvi.01634-12 |
0.392 |
|
| 2012 |
Hunt CL, Lennemann NJ, Maury W. Filovirus entry: a novelty in the viral fusion world. Viruses. 4: 258-75. PMID 22470835 DOI: 10.3390/V4020258 |
0.744 |
|
| 2011 |
Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, Moller-Tank S, Meyerholz DK, Rennert P, Mullins RF, Brindley M, Sandersfeld LM, Quinn K, Weller M, McCray PB, Chiorini J, ... Maury W, et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proceedings of the National Academy of Sciences of the United States of America. 108: 8426-31. PMID 21536871 DOI: 10.1073/Pnas.1019030108 |
0.701 |
|
| 2011 |
Brindley MA, Hunt CL, Kondratowicz AS, Bowman J, Sinn PL, McCray PB, Quinn K, Weller ML, Chiorini JA, Maury W. Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology. 415: 83-94. PMID 21529875 DOI: 10.1016/J.Virol.2011.04.002 |
0.475 |
|
| 2011 |
Hunt CL, Kolokoltsov AA, Davey RA, Maury W. The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. Journal of Virology. 85: 334-47. PMID 21047970 DOI: 10.1128/Jvi.01278-09 |
0.334 |
|
| 2009 |
Quinn K, Brindley MA, Weller ML, Kaludov N, Kondratowicz A, Hunt CL, Sinn PL, McCray PB, Stein CS, Davidson BL, Flick R, Mandell R, Staplin W, Maury W, Chiorini JA. Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. Journal of Virology. 83: 10176-86. PMID 19625394 DOI: 10.1128/Jvi.00422-09 |
0.468 |
|
| 2008 |
Brindley MA, Zhang B, Montelaro RC, Maury W. An equine infectious anemia virus variant superinfects cells through novel receptor interactions. Journal of Virology. 82: 9425-32. PMID 18667522 DOI: 10.1128/Jvi.01142-08 |
0.367 |
|
| 2008 |
Tallmadge RL, Brindley MA, Salmans J, Mealey RH, Maury W, Carpenter S. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus. Clinical and Vaccine Immunology : Cvi. 15: 1138-40. PMID 18448619 DOI: 10.1128/Cvi.00088-08 |
0.431 |
|
| 2007 |
Brindley MA, Hughes L, Ruiz A, McCray PB, Sanchez A, Sanders DA, Maury W. Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. Journal of Virology. 81: 7702-9. PMID 17475648 DOI: 10.1128/Jvi.02433-06 |
0.511 |
|
| 2005 |
Maury W, Thompson RJ, Jones Q, Bradley S, Denke T, Baccam P, Smazik M, Oaks JL. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism. Journal of Virology. 79: 5653-64. PMID 15827180 DOI: 10.1128/Jvi.79.9.5653-5664.2005 |
0.307 |
|
| 2001 |
Hines R, Maury W. DH82 cells: A macrophage cell line for the replication and study of equine infectious anemia virus Journal of Virological Methods. 95: 47-56. PMID 11377712 DOI: 10.1016/S0166-0934(01)00288-9 |
0.314 |
|
| 2000 |
Maury W, Bradley S, Wright B, Hines R. Cell specificity of the transcription-factor repertoire used by a lentivirus: Motifs important for expression of equine infectious anemia virus in nonmonocytic cells Virology. 267: 267-278. PMID 10662622 DOI: 10.1006/Viro.1999.0144 |
0.36 |
|
| 1989 |
Koenig S, Hirsch VM, Olmsted RA, Powell D, Maury W, Rabson A, Fauci AS, Purcell RH, Johnson PR. Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion Proceedings of the National Academy of Sciences of the United States of America. 86: 2443-2447. PMID 2784571 DOI: 10.1073/Pnas.86.7.2443 |
0.352 |
|
| Show low-probability matches. |